Siegenthaler, B.; Ghayor, C.; Gjoksi-Cosandey, B.; Ruangsawasdi, N.; Weber, F.E.
The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes. Int. J. Mol. Sci. 2018, 19, 3332.
https://doi.org/10.3390/ijms19113332
AMA Style
Siegenthaler B, Ghayor C, Gjoksi-Cosandey B, Ruangsawasdi N, Weber FE.
The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes. International Journal of Molecular Sciences. 2018; 19(11):3332.
https://doi.org/10.3390/ijms19113332
Chicago/Turabian Style
Siegenthaler, Barbara, Chafik Ghayor, Bebeka Gjoksi-Cosandey, Nisarat Ruangsawasdi, and Franz E. Weber.
2018. "The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes" International Journal of Molecular Sciences 19, no. 11: 3332.
https://doi.org/10.3390/ijms19113332
APA Style
Siegenthaler, B., Ghayor, C., Gjoksi-Cosandey, B., Ruangsawasdi, N., & Weber, F. E.
(2018). The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes. International Journal of Molecular Sciences, 19(11), 3332.
https://doi.org/10.3390/ijms19113332